1. Alzheimer’s disease and its treatment by different approaches: a review;Srivastava;Eur. J. Med. Chem.,2021
2. Shi En Kim FDA to review another Alzheimer’s antibody Chemical & Engineering News 100 25 2022 12 12.
3. H. Devlin H.D.S. correspondent, Success of experimental Alzheimer’s drug hailed as ‘historic moment’ The Guardian. 2022 accessed October 31, 2022). A. King, Biogen-Eisai’s second Alzheimer’s antibody approved in the US, ChemistryWorld, 20 (2023) 18. Second Alzheimer’s antibody approved in the US | Business | Chemistry World https://www.theguardian.com/society/2022/sep/28/alzheimers-disease-progression-slowed-by-new-drug-lecanemab.
4. Changes in health care use by mexican american medicare beneficiaries before and after a diagnosis of dementia;Downer;J. Gerontol.: Ser. A,2021
5. Oxindole and its derivatives: A review on recent progress in biological activities;Khetmalis;Biomed. Pharmacother.,2021